ACR 2016 Preview: Vasculitis
Can vaccinations prevent GCA in patients with compromised immune systems? In this slideshow, we highlight three of many studies on vasculitis due to be presented at ACR 2016 later this week.
Can vaccinations prevent GCA in patients with compromised immune systems? Does a urinalysis test detect renal relapse in patients? In this slideshow, we highlight three of many studies on advances in vasculitis research. The presentations are due to be presented at the American College of Rheumatology 2016 annual meeting Nov. 11-16 in Washington, D.C.
©AlilaMedicalMedia/Shutterstock.com
“Herpes Zoster and the Risk of Incident Giant Cell Arteritis,” Bryant R. England. Abstract number 2074. 2016 ACR/ARHP Annual Meeting. 4:30 p.m., Nov. 14, 2016.http://acrabstracts.org/abstract/herpes-zoster-and-the-risk-of-incident-giant-cell-arteritis/
“The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis,” Rennie L. Rhee. 2016 ACR/ARHP Annual Meeting. Abstract number 3181. 9:30 a.m., Nov. 16, 2016. http://acrabstracts.org/abstract/the-utility-of-urinalysis-in-determining-the-risk-of-renal-relapse-in-anca-associated-vasculitis/
“A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Takayasu’s Arteritis,” Carol A. Langford. ACR/ARHP Annual Meeting. Abstract number 979. 3:30 p.m., Nov. 13, 2016. http://acrabstracts.org/abstract/a-randomized-double-blind-trial-of-abatacept-and-glucocorticoids-for-the-treatment-of-takayasus-arteritis/
